| Date Filed | Type | Description |
| 10/13/2023 |
8-K
| Quarterly results |
| 10/11/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 10/11/2023 |
8-K
| Quarterly results |
| 10/06/2023 |
SC 13G/A
| BlackRock Inc. reports a 10.2% stake in Harmony Biosciences Holdings, Inc. |
| 10/05/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 10/04/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 09/27/2023 |
SC TO-T/A
| Form SC TO-T/A - Tender offer statement by Third Party: [Amend] |
| 08/24/2023 |
SC 13D
| Harmony Biosciences Holdings, Inc. reports a 13.1% stake in ZYNERBA PHARMACEUTICALS, INC. |
| 08/14/2023 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 08/14/2023 |
8-K
| Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits Inte... |
| 08/14/2023 |
SC TO-C
| Form SC TO-C - Written communication relating to an issuer or third party: |
| 08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/01/2023 |
8-K
| Quarterly results |
| 07/27/2023 |
8-K
| Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financi... |
| 05/31/2023 |
8-K/A
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 05/31/2023 |
4/A
| Dayno Jeffrey M. (PRESIDENT, CEO) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Granted 125,000 options
@ $0 |
|
| 05/30/2023 |
4
| Dayno Jeffrey M. (PRESIDENT, CEO) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Granted 125,000 options
@ $35.99, valued at
$4.5M
|
|
| 05/26/2023 |
4
| Nielsen Jack (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Granted 5,224 options
@ $35.99, valued at
$188k
|
|
| 05/26/2023 |
4
| Sender Gary (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Granted 9,613 options
@ $35.99, valued at
$346k
|
|
| 05/26/2023 |
4
| Graf R. Mark (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Granted 5,224 options
@ $35.99, valued at
$188k
|
|
| 05/26/2023 |
4
| Sabater Juan A. (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Granted 5,224 options
@ $35.99, valued at
$188k
|
|
| 05/26/2023 |
4
| Gracias Antonio J. (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Granted 7,314 options
@ $35.99, valued at
$263.2k
|
|
| 05/26/2023 |
4
| Szyper Linda M (Director) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Granted 5,224 options
@ $35.99, valued at
$188k
|
|
| 05/26/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/02/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 05/02/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/02/2023 |
8-K
| Quarterly results |
| 04/24/2023 |
8-K
| Quarterly results |
| 04/14/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/14/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/14/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 03/31/2023 |
4
| Kapadia Sandip (CFO) has filed a Form 4 on Harmony Biosciences Holdings, Inc.|
Txns:
| Paid exercise price by delivering 15,414 shares
@ $33.36, valued at
$514.2k
Exercised 30,000 restricted stock units
@ $0 |
|
| 03/29/2023 |
8-K
| Quarterly results |
| 03/10/2023 |
8-K
| Other Events Interactive Data |
|